-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Integrated Biopharma Inc quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q3 2018 to Q3 2023.
- Integrated Biopharma Inc Deferred Income Tax Expense (Benefit) for the quarter ending September 30, 2023 was $8K, a 78.4% decline year-over-year.
- Integrated Biopharma Inc annual Deferred Income Tax Expense (Benefit) for 2023 was $72K.
- Integrated Biopharma Inc annual Deferred Income Tax Expense (Benefit) for 2022 was -$1.53M, a 10.5% decline from 2021.
- Integrated Biopharma Inc annual Deferred Income Tax Expense (Benefit) for 2021 was -$1.39M, a 2.67% decline from 2020.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)